Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCRIPT-AML: CloFluBu vs BuCyMel in Pediatric AML
NCT05477589Phase 3Recruiting
- Sponsor
- Region Västra Götaland
- Start
- Jun 2022
- Primary completion
- Dec 2029
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 10
01
Overview
A Phase 3 trial of clofarabine, fludarabine in acute myeloid leukemia (AML), sponsored by Region Västra Götaland. Started Jun 2022; status: recruiting.
02
Drugs
clofarabinefludarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT05477589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05477589.